Laurus Labs (BOM:540222) Total Stockholders Equity : ₹41,110 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Laurus Labs Total Stockholders Equity?

Laurus Labs's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹41,110 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Laurus Labs's Book Value per Share for the quarter that ended in Mar. 2024 was ₹76.25. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Laurus Labs's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.63.

Laurus Labs Total Stockholders Equity Historical Data

The historical data trend for Laurus Labs's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laurus Labs Total Stockholders Equity Chart

Laurus Labs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Stockholders Equity

Get a 7-Day Free Trial

17,697.70

25,975.50

33,511.90

40,375.30

41,109.50

Laurus Labs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															40,375.30	-	40,298.20	-	41,109.50

Laurus Labs (BOM:540222) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Laurus Labs's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(41109.5	-	0)	/	539.159
	=	76.25

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Laurus Labs's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(17170.1	+	8603.9)	/	41109.5
	=	0.63

Laurus Labs Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Laurus Labs's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Laurus Labs (BOM:540222) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laurus Labs Ltd (BOM:540222) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

LAURUSLABS:India

Address

Road No. 7, Banjara Hills, 2nd Floor, Serene Chambers, Hyderabad, TG, IND, 500034

Website

https://www.lauruslabs.com

Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.

Laurus Labs (BOM:540222) Headlines

No Headlines